e-learning
resources
Virtual 2020
Pre-Congress Content
Respiratory viruses in the "pre COVID-19" era
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Combination of nitazoxanide with oseltamivir compared with oseltamivir in hospitalized patients with influenza
P. Koul (Srinagar (Jammu and Kashmir), India), H. Mir (Srinagar (Jammu and Kashmir), India), T. Shah (Srinagar (Jammu and Kashmir), India)
Source:
Virtual Congress 2020 – Respiratory viruses in the "pre COVID-19" era
Session:
Respiratory viruses in the "pre COVID-19" era
Session type:
E-poster session
Number:
2386
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Koul (Srinagar (Jammu and Kashmir), India), H. Mir (Srinagar (Jammu and Kashmir), India), T. Shah (Srinagar (Jammu and Kashmir), India). Combination of nitazoxanide with oseltamivir compared with oseltamivir in hospitalized patients with influenza. 2386
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Limited effect of clarithromycin in non-elderly, non-severe patients with influenza
Source: Annual Congress 2012 - Viral infections and rare respiratory infections
Year: 2012
Severe influenza A H7N9 pneumonia with rapid virological response to intravenous zanamivir
Source: Eur Respir J 2014; 44: 535-537
Year: 2014
Efficacy and safety of levofloxacin treatment of community-acquired pneumonia in hospitalized patients
Source: Eur Respir J 2005; 26: Suppl. 49, 637s
Year: 2005
Early oseltamivir treatment improves survival in critically ill patients with influenza pneumonia
Source: ERJ Open Res, 7 (1) 00888-2020; 10.1183/23120541.00888-2020
Year: 2021
Efficacy of the neuraminidase inhibitors in treating influenza pneumonia
Source: Eur Respir J 2004; 24: Suppl. 48, 186s
Year: 2004
Comparison of treatment outcomes in community-acquired pneumonia patients treated with beta lactam-macrolide combination versus fluoroquinolone monotherapy
Source: Annual Congress 2012 - Management of severe respiratory infections
Year: 2012
Efficacy of influenza and pneumococcal vaccinations among patients with COPD
Source: Annual Congress 2007 - Treatment of COPD
Year: 2007
Neuraminidase inhibitors, superinfection and corticosteroids affect survival of influenza patients
Source: Eur Respir J 2015; 45: 1642-1652
Year: 2015
Comparison of ampicillin-sulbactam/macrolide dual therapy versus fluoroquinolone monotherapy in hospitalized patients with community-acquired pneumonia
Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants
Year: 2015
Barriers to an early switch from intravenous to oral antibiotic therapy in hospitalised patients with CAP
Source: Eur Respir J 2013; 41: 123-130
Year: 2013
Combination therapy (beta-lactam+macrolide) vs fluoroquinolone monotherapy for the treatment of CAP
Source: Annual Congress 2012 - Management of severe respiratory infections
Year: 2012
Early use of oseltamivir protected from respiratory failure in patients with acute flu syndrome during 2009 Brazilian influenza H1N1 pandemics
Source: Annual Congress 2010 - Influenza A (H1N1) and other viral infections: therapeutic aspects
Year: 2010
Monotherapy with β-lactamic antibiotics or macrolides vs their combination for the treatment of community acquired pneumonia (CAP)
Source: Annual Congress 2008 - Lower respiratory tract infection: from outbreak to prognostic tests
Year: 2008
Randomised controlled trial of sequential intravenous and oral azithromycin compared with intravenous ceftriaxone followed by cefixime both in combination with clarithromycin in hospitalized patients with community-acquired pneumonia
Source: Annual Congress 2011 - Antimicrobial treatment and resistance in lower respiratory tract infections
Year: 2011
Combination versus monotherapy for nosocomial pneumonia
Source: Eur Respir Rev 2007; 16: 50-55
Year: 2007
Adjunctive systemic corticosteroid treatment in hospitalized patients with community-acquired pneumonia
Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections
Year: 2012
Tolerability of rifapentine-based regimens in latent tuberculosis infection treatment in the elderly
Source: Eur Respir J, 53 (3) 1802396; 10.1183/13993003.02396-2018
Year: 2019
A regimen containing bedaquiline and delamanid compared to bedaquiline in patients with drug-resistant tuberculosis
Source: Eur Respir J, 55 (1) 1901181; 10.1183/13993003.01181-2019
Year: 2020
Efficacy of corticosteroids in hospital treated community-acquired pneumonia
Source: Annual Congress 2012 - Clinical management of lung diseases: from bronchi to pleura
Year: 2012
Duration of therapy in hospitalised patients with CAP
Source: Annual Congress 2007 - An international perspective of the management of hospitalised patients with community-acquired pneumonia
Year: 2007
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept